|1.||Siraki, Arno G: 3 articles (09/2015 - 07/2007)|
|2.||Harvey, Philip W: 2 articles (01/2016 - 03/2003)|
|3.||Michail, Karim: 2 articles (09/2015 - 07/2011)|
|4.||Tausch, Christoph: 2 articles (12/2007 - 03/2003)|
|5.||Mlineritsch, Brigitte: 2 articles (12/2007 - 03/2003)|
|6.||Schmid, Marianne: 2 articles (12/2007 - 03/2003)|
|7.||Samonigg, Hellmut: 2 articles (12/2007 - 03/2003)|
|8.||Kwasny, Werner: 2 articles (12/2007 - 03/2003)|
|9.||Gnant, Michael: 2 articles (12/2007 - 03/2003)|
|10.||Kubista, Ernst: 2 articles (12/2007 - 03/2003)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/1986 - "Several specific suicide inhibitors of aminoglutethimide such as 4-hydroxy-androstenedione are being developed and have proven effective in early clinical trials with breast cancer patients. "
10/01/1986 - "It is concluded that aminoglutethimide alone is effective in the treatment of postmenopausal patients with breast cancer. "
07/01/1985 - "Aminoglutethimide without glucocorticoid has been shown to be a clinically effective treatment for postmenopausal breast cancer in low dosage (250 mg day-1). "
01/01/1985 - "Aminoglutethimide is an effective treatment for advanced postmenopausal breast cancer, acting in a novel way. "
10/01/1997 - "In a European multicentre phase II study, 80 postmenopausal patients (pts) with advanced breast cancer progressing on aminoglutethimide (AG) at daily doses of > or = 500 mg were enrolled. "
01/01/1989 - "On the other hand, when aminoglutethimide was administered with delta 5-diol, the stimulatory effect of the adrenal steroid on tumor growth was not affected. "
05/01/1987 - "Aminoglutethimide: a toxic object lesson in the endocrine management of cancer."
01/01/1984 - "Both patients developed severe complications when treated with aminoglutethimide as a cancer hormonal therapy. "
01/01/1989 - "Our results show that ovariectomy or aminoglutethimide treatment slowed down the MXT tumor growth without any additive effect between them. "
06/01/1979 - "Three of fourteen patients experienced partial objective tumor regression with a median duration of 4.6 months following hypophysectomy, whereas 10 of 21 women receiving aminoglutethimide responded (2 complete, 8 partial) with a median duration of 11.5 months. "
09/01/1981 - "Administration of aminoglutethimide to patients with Cushing's syndrome results in improvement in clinical status in 56% of cases. "
03/14/1983 - "[Aminoglutethimide in the treatment of Cushing's syndrome (observation of 10 cases)]."
11/01/1976 - "The efficacy and tolerability of aminoglutethimide for the treatment of Cushing's syndrome was assessed in 66 cases three of which are described in the present paper. "
11/01/1976 - "Aminoglutethimide in the treatment of Cushing's syndrome."
02/20/1974 - "[Proceedings: Case of Cushing's syndrome with remarkable improvement observed with administration of aminoglutethimide]."
04/01/2005 - "Some newer aminoglutethimide derivatives 37-39 have also been prepared in order to study the effect of N-substitution on its pharmacological profile for the treatment of carcinoma. "
01/01/1986 - "Clinical studies with aminoglutethimide in advanced breast carcinoma."
09/01/1971 - "[Clinico-hormonological study of the effects of aminoglutethimide in a case of adrenal cortex carcinoma]."
09/01/1999 - "[Aminoglutethimide in the treatment of metastatic breast carcinoma]."
04/01/1989 - "[Orimeten in the treatment of advanced carcinoma of the prostate]."
|5.||Neoplasm Metastasis (Metastasis)
11/25/2000 - "In addition, Th1 cell responses were restored and pulmonary metastasis was reduced by aminoglutethimide. "
01/01/1990 - "This patient was started on aminoglutethimide 6 days prior to radiation therapy, for painful bone metastasis. "
07/01/1988 - "Due to its potentially enhanced objective and more pronounced subjective side-effects, aminoglutethimide may be preferred in bone metastases. "
11/07/1986 - "Thus, simultaneous combination of aminoglutethimide and polychemotherapy containing anthracycline derivatives is the most effective therapeutic regimen for those patients who were either pretreated or have progressive bone metastases with confinement to bed or have concomitant visceral metastases."
12/31/1985 - "Aminoglutethimide provides effective treatment in patients with generalized metastatic breast cancer followed by best outcome in cases with osseous metastases. "
|9.||Megestrol Acetate (Borea)
|2.||Combination Drug Therapy (Combination Chemotherapy)
|5.||Drug Therapy (Chemotherapy)